Genetics-based personalized health company that develops genetic tests for use in the emerging personalized health market.
Total raised: $12M
Investors 2
| Date | Name | Website |
| 03.07.2021 | New Enterp... | nea.com |
| - | Bay City C... | baycitycap... |
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 20.05.2013 | - | $12M | - | baycitycap... |
Mentions in press and media 7
| Date | Title | Description | Category | Author | Source |
| 04.08.2017 | Learning f... | Developing and commercializing... | - | - | medcitynew... |
| 20.05.2013 | Interleuki... | WALTHAM, Mass. – May 20, 2013 ... | - | - | baycitycap... |
| 15.11.2010 | Clinical t... | Cardiac resynchronization-ther... | - | MassDevice... | massdevice... |
| 30.04.2010 | Interleuki... | Interleukin Genetics Inc. (NYS... | - | MassDevice... | massdevice... |
| 05.03.2010 | Interleuki... | Interleukin Genetics Inc. (NYS... | - | MassDevice... | massdevice... |
| 02.03.2010 | Interleuki... | Interleukin Genetics Inc. (NYS... | - | MassDevice... | massdevice... |
| - | Learning f... | In the aftermath of the Theran... | - | - | medcitynew... |